ATE360432T1 - Peptid zur behandlung von nervenerkrankungen - Google Patents
Peptid zur behandlung von nervenerkrankungenInfo
- Publication number
- ATE360432T1 ATE360432T1 AT00957052T AT00957052T ATE360432T1 AT E360432 T1 ATE360432 T1 AT E360432T1 AT 00957052 T AT00957052 T AT 00957052T AT 00957052 T AT00957052 T AT 00957052T AT E360432 T1 ATE360432 T1 AT E360432T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- treatment
- nerve diseases
- agent
- diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 210000005036 nerve Anatomy 0.000 title 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- 229940125682 antidementia agent Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229930195712 glutamate Natural products 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000002664 nootropic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25515999A JP2001072602A (ja) | 1999-09-09 | 1999-09-09 | 神経疾患治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE360432T1 true ATE360432T1 (de) | 2007-05-15 |
Family
ID=17274893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00957052T ATE360432T1 (de) | 1999-09-09 | 2000-09-08 | Peptid zur behandlung von nervenerkrankungen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1210948B8 (de) |
| JP (1) | JP2001072602A (de) |
| KR (1) | KR100699737B1 (de) |
| CN (1) | CN1170585C (de) |
| AT (1) | ATE360432T1 (de) |
| AU (1) | AU6876200A (de) |
| DE (1) | DE60034580T2 (de) |
| WO (1) | WO2001017545A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4188115B2 (ja) | 2003-03-14 | 2008-11-26 | ブラザー工業株式会社 | 画像形成装置 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE113606T1 (de) * | 1989-04-15 | 1994-11-15 | Nippon Chemiphar Co | Peptide und diese peptide enthaltende wirkstoffe gegen dementia. |
| JPH11171786A (ja) * | 1997-12-12 | 1999-06-29 | Nippon Chemiphar Co Ltd | ペプチドを有効成分として含有する向精神薬 |
-
1999
- 1999-09-09 JP JP25515999A patent/JP2001072602A/ja active Pending
-
2000
- 2000-09-08 KR KR1020027003123A patent/KR100699737B1/ko not_active Expired - Fee Related
- 2000-09-08 WO PCT/JP2000/006150 patent/WO2001017545A1/ja not_active Ceased
- 2000-09-08 EP EP00957052A patent/EP1210948B8/de not_active Expired - Lifetime
- 2000-09-08 AT AT00957052T patent/ATE360432T1/de not_active IP Right Cessation
- 2000-09-08 DE DE60034580T patent/DE60034580T2/de not_active Expired - Fee Related
- 2000-09-08 AU AU68762/00A patent/AU6876200A/en not_active Abandoned
- 2000-09-08 CN CNB008150532A patent/CN1170585C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1170585C (zh) | 2004-10-13 |
| JP2001072602A (ja) | 2001-03-21 |
| KR100699737B1 (ko) | 2007-03-27 |
| WO2001017545A1 (fr) | 2001-03-15 |
| DE60034580T2 (de) | 2007-12-27 |
| EP1210948A4 (de) | 2004-07-28 |
| EP1210948A1 (de) | 2002-06-05 |
| EP1210948B1 (de) | 2007-04-25 |
| KR20020041811A (ko) | 2002-06-03 |
| CN1384752A (zh) | 2002-12-11 |
| DE60034580D1 (de) | 2007-06-06 |
| EP1210948B8 (de) | 2007-07-04 |
| AU6876200A (en) | 2001-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| DE60225719D1 (de) | Cis-2,4,5- triphenyl-imidazoline und ihre verwendung bei der behandlung von tumoren | |
| EA200200208A1 (ru) | Синергитическая композиция | |
| FI950309A0 (fi) | Proliiniamidijohdannaisia | |
| MXPA04001037A (es) | Derivados de n-fenilpirrol guanidina como ligandos del receptor de melanocortina. | |
| DE60026155D1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
| EA200400022A1 (ru) | Соединения и способы лечения или предупреждения инфекций flavivirus | |
| NO20003233L (no) | 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler | |
| ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| ATE388951T1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| NO20034204L (no) | Farmasöytiske kombinasjoner til behandling av kreft | |
| ATE337316T1 (de) | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen | |
| ATE399782T1 (de) | Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen | |
| DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| BRPI0513750A (pt) | 2-fenilamino-benzamidas-5-substituìdas como inibidoras de mek | |
| DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| EA200100141A1 (ru) | Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| EA200100140A1 (ru) | Терапевтическая композиция на основе флавоноидов для применения в лечении опухолей цитотоксическими агентами | |
| BR9909870A (pt) | Pirrolidinas como inibidores de neuraminidases | |
| EA200201232A1 (ru) | Производные сульфонамида | |
| DE60034580D1 (de) | Peptid zur behandlung von nervenerkrankungen | |
| EA200201234A1 (ru) | Производные сульфонамида |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |